Tests a supplement mix against a placebo in children with autism
Compares a bee-product and plant supplement mix with a placebo in children with autism.
Plain-language title generated from the registry record
Registry title: Combination of Supplements for Treating Autistic Spectrum Disorder
Key facts
- Where
- Bucharest and Constanța, RomaniaSee the 2 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children aged 3 to 14 with autism spectrum disorder who can take oral treatment and attend all study visits and tests.
- Age
- 3 to 14 years
- Sex
- All sexes can join.
- Disease stage
- Typical or atypical autism spectrum disorder (F84.0 or F84.1).
- Earlier treatment
- Must have had at least one therapeutic intervention before joining. Must not be in another interventional trial now or have finished one less than 1 month ago.
- Biomarker or test result
- Ferritin, homocysteine, HgbA1c and ESR must not be abnormally high at the first visit (V1).
Main reasons for not taking part
- Known allergy to hive products, the studied substances, or celery and related plants
- Diabetes
- History of seizures or epilepsy
- Taking blood thinners, anticonvulsants, insulin, MAO inhibitors, NSAIDs or thiazide diuretics
- Cannot manage 3 visits, 3 psychometric assessments and 3 sets of blood tests
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 14 years old?
Source: NCT06756711, who can take part
Where in Romania
- Clinica Aide SanteBucharest, RomaniaNo longer taking part
- Medical Link SRLConstanța, RomaniaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Fundatia Bio-Forum
- Trial code
- NCT06756711
- Record updated
- 3 January 2025
- Original description
A pilot study to compare the efficacy of a combination of apitherapy supplements versus placebo in children with autistic spectrum disorder.Read full original descriptionShow less
Combination of Supplements for Treating Autistic Spectrum Disorder
A pilot study to compare the efficacy of a combination of apitherapy supplements versus placebo in children with autistic spectrum disorder.
Inclusion: age 3-14 years; diagnosed with typical or atypical autism spectrum disorder (F84.0 or F84.1) and received at least one therapeutic intervention before enrolling; the ability to follow an oral treatment, with TID/BID/QD administration; the availability to perform 3 sets of blood tests at a clinical laboratory within 6 months (initial, at 3- and 6-months); the availability to perform 3 visits to the Investigator and 3 psychometric evaluations within 6 months.
Exclusion: patients enrolled in another interventional clinical trial currently or which ended less than 1 month prior to enrolling in this study; administration of anticoagulants, antiplatelets, thrombolytic agents, low molecular weight heparins, anticonvulsants, insulin, monoamine oxidase inhibitors, non-steroidal anti-inflammatory drugs or thiazide diuretics; known allergy to hive products or one of the substances studied; diagnosis of diabetes; history of seizures/epilepsy; allergy to celery and other plants of the Fam. Apiaceaea (Umbelliferae); inability to perform the study requirements (3 visits to the Investigator, 3 psychometric assessments, 3 sets of blood tests); abnormally elevated baseline (at V1) values of ferritin, homocysteine, HgbA1c, ESR.